4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-17-000073
$JAZZCIK 0001232524operating
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:39 PM ET
Size
7.1 KB
Accession
0001232524-17-000073
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2017-03-06$131.97/sh−355$46,851→ 18,108 total - Sale
Ordinary Shares
2017-03-06$131.97/sh−529$69,815→ 17,579 total
Footnotes (3)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.4935 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $131.5330 to $131.9800. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:39 PM ET
- Size
- 7.1 KB